New Delhi: In a big move, Bharat Biotech’s Covaxin has reportedly received approval from Subject Expert Committee (SEC) on COVID-19 for emergency use in children above 2 years in India.
The SEC has submitted recommendations to Drugs Controller General of India (DCGI) for approval of the vaccine for use on children, stated reports.
Once approved, Covaxin will become only second vaccine cleared for use on kids and the only such vaccine for toddlers too. In August, Zydus Cadilla’s three-dose DNA jab was allowed to be used on adults and children over 12.
The Hyderabad-based company had completed Phase-2 and Phase-3 trials of Covaxin on children below 18 years of age in September.
A third potential vaccine for kids is Serum Institute’s Novavax, for which the DCGI last month cleared trials for children between seven and 11 years.
Mumbai: Television actress Hina Khan, who is battling breast cancer, recently met host Salman Khan…
Mumbai: Following reports of his alleged link-up with bassist Mohini Dey, renowned music composer AR…
Mumbai: The love story of actors Tamannaah Bhatia and Vijay Varma has not been clandestine.…
Puri: Shree Jagannath Temple Administration (SJTA) has received the report of the Ratna Bhandar’s GPR-GPS…
With his debut novel ‘The Other Side of the Rainbow’ published recently, Niranjan Nayak, an…
Bhubaneswar: Odisha outplayed Chhattisgarh 4-1 on Saturday to seal a berth in the final round…
Mumbai: The Telangana government’s notice barring him from singing songs promoting alcohol and drugs at…
Bhubaneswar: Prime Minister Narendra Modi will participate in the ‘Odisha Parba 2024’ programme on Sunday…